FDA Rejects Namenda
Tuesday August 2, 2005
The FDA have come out against offering namenda for mild to moderate Alzheimer's. Mixed research findings have tipped the balance against namenda.
Carrie Hill, PhD's Alzheimer's Disease Blog
From Carrie Hill, PhD, for About.com
Explore Alzheimer's Disease
Must Reads
About.com Special Features
Learn how you can reduce your your numbers with these nutrition and exercise tips. More >
Keep yourself, and your family, happy and healthy this fall with these tips. More >
Also from About.com:
©2009 About.com, a part of The New York Times Company.
All rights reserved.
Comments
No comments yet. Leave a Comment